Clinical Trials Browser

Phase 1 × Epstein-Barr Virus Infections × Clear all

NCT07478952 2026-03-18

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189 in Healthy Adults 18 to 30 Years of Age

Phase 1 Not yet recruiting

Epstein-Barr Virus Infections

NCT06908096 2026-03-06

Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection

Phase 1 Recruiting

Infectious Mononucleosis, Epstein-Barr Virus Infections

NCT05389423 2026-02-19

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

Phase 1 Recruiting

Plasmablastic Lymphoma, Burkitt Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Epstein-Barr Virus Infections

NCT04664179 2025-12-12

CILESTE

Phase 1 Recruiting

Hodgkin Disease, Lymphoma, Non-Hodgkin, Epstein-Barr Virus Infections

NCT05831111 2025-09-30

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants

Phase 1 Active not recruiting

Infections, Infectious Mononucleosis, Virus Diseases, Epstein-Barr Virus Infections

NCT04013802 2025-08-08

TETRAVI

Phase 1 Recruiting

Adenoviridae Infections, Virus Diseases, Epstein-Barr Virus Infections

NCT06926894 2025-07-31

R-MVST Cells for Treatment of Viral Infections in Children and Young Adults

Phase 1 Recruiting

Adenoviridae Infections, Cytomegalovirus Infections, Immunologic Deficiency Syndromes, Epstein-Barr Virus Infections

NCT06429800 2025-04-24

A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Systemic Lupus Erythematosus

Phase 1 Withdrawn

Lupus Erythematosus, Systemic, Lupus Nephritis, Epstein-Barr Virus Infections

NCT05183490 2024-12-30

R-MVST Cells for Treatment of Viral Infections

Phase 1 Recruiting

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT06119256 2023-11-07

Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT

Phase 1 Recruiting

Epstein-Barr Virus Infections

NCT01535885 2021-10-25

ACE

Phase 1 Completed

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT00058591 2020-01-18

SCAEBV

Phase 1 Completed

Epstein-Barr Virus Infections

NCT01800071 2018-07-17

A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma

Phase 1 Completed

Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections

NCT02761291 2016-05-16

Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma

Phase 1 Unknown

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence, Epstein-Barr Virus Infections, Multiple Acyl Coenzyme A Dehydrogenase Deficiency

NCT00706316 2015-07-10

NPC-CTL

Phase 1 Completed

Nasopharyngeal Neoplasms, Neoplasm Metastasis, Recurrence, Epstein-Barr Virus Infections

NCT00058812 2015-01-29

ETNA

Phase 1 Completed

Epstein-Barr Virus Infections

NCT01070797 2014-09-04

VIRAGE

Phase 1 Completed

Adenoviridae Infections, Cytomegalovirus Infections, Virus Diseases, Epstein-Barr Virus Infections

NCT00078546 2012-07-30

CLANC

Phase 1 Completed

Carcinoma, Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections

NCT00779337 2012-05-22

EPL

Phase 1 Completed

Lymphoma, Epstein-Barr Virus Infections

NCT01147991 2012-02-28

Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer

Phase 1 Completed

GastrointestinalHead & NeckLymphoid

Burkitt Lymphoma, Head and Neck Neoplasms, Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoproliferative Disorders, Nasopharyngeal Neoplasms, Stomach Neoplasms, Lymphoma, Large-Cell, Immunoblastic, Epstein-Barr Virus Infections, Lymphoma, Extranodal NK-T-Cell